The Prognostic Significance of the Depth of Cervical Stromal Invasion in Women With FIGO Stage II Uterine Endometrioid Carcinoma

被引:3
作者
Al Khatib, Sondos [1 ]
Bhatnagar, Aseem [1 ]
Elshaikh, Noor [1 ]
Ghanem, Ahmed I. [1 ,5 ]
Burmeister, Charlotte [2 ]
Allo, Ghassan [3 ]
Alkamachi, Bassam [3 ]
Paridon, Alex [4 ]
Elshaikh, Mohamed A. [1 ]
机构
[1] Henry Ford Canc Inst, Dept Radiat Oncol, 2800 W Grand Blvd, Detroit, MI 48202 USA
[2] Henry Ford Canc Inst, Dept Publ Hlth, Detroit, MI 48202 USA
[3] Henry Ford Canc Inst, Dept Pathol, Detroit, MI 48202 USA
[4] Henry Ford Canc Inst, Dept Womens Hlth Serv, Div Gynecol Oncol, Detroit, MI 48202 USA
[5] Alexandria Univ, Alexandria Clin Oncol Dept, Fac Med, Alexandria, Egypt
来源
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 2023年 / 46卷 / 10期
关键词
endometrial carcinoma; stage II; cervical stromal invasion; adjuvant; hysterectomy; prognosis; CANCER; RECURRENCE; SURVIVAL; BRACHYTHERAPY; RADIOTHERAPY; INTERVAL;
D O I
10.1097/COC.0000000000001033
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: The objective of this study was to investigate the prognostic significance of the depth of cervical stromal invasion (CSI) in women with FIGO stage II uterine endometrioid adenocarcinoma (EC).Methods: Our database of women with EC was quired for patients with stage II EC. Pathologic slides were retrieved and reviewed by gynecologic pathologists to determine cervical stromal thickness and depth of CSI as a percentage of stromal thickness (%CSI). Kaplan-Meier, univariate, and multivariate analyses were used to compare recurrence-free, disease-specific (DSS), and overall survival (OS) between women who had<50% versus = 50% CSI. Univariate and multivariate analyses were used to assess other prognostic variables associated with survival endpoints.Results: A total of 117 patients were included in our study who had hysterectomy between 1/1990 and 8/2021. Seventy-nine patients (68%) with <50% and 38 (32w%) with = 50% CSI. After a median follow-up of 131 months, 5-year DSS was significantly worse for women with = 50% CSI (78% vs. 91%; P=0.04). However, %CSI was not an independent predictor for any of the studied survival endpoints. Independent predictors of worse 5-year recurrence-free survival and DSS included FIGO grade 3 tumors (P=0.02) and the presence of lymphovascular space invasion (P=0.03). Grade 3 tumors were the only independent predictor of worse 5-year OS (P=0.02).Conclusions: Our results suggest that deep CSI is not an independent prognostic factor for survival endpoints in women with stage II uterine endometroid adenocarcinoma. The lack of independent prognostic significance of the depth CSI needs to be validated in a multi-institutional analysis.
引用
收藏
页码:445 / 449
页数:5
相关论文
共 50 条
  • [21] Histologic study of patterns of cervical involvement in FIGO stage II endometrial carcinoma
    Scurry, J
    Craighead, P
    Duggan, M
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2000, 10 (06) : 497 - 502
  • [22] The impact of lymphadenectomy on survival endpoints in women with early stage uterine endometrioid carcinoma: A matched analysis
    Ghanem, Ahmed I.
    Khan, Nadia T.
    Mahan, Meredith
    Ibrahim, Ahmed
    Buekers, Thomas
    Elshaikh, Mohamed A.
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2017, 210 : 225 - 230
  • [23] Stage II recurrent nasopharyngeal carcinoma: Prognostic significance of retropharyngeal nodal metastasis, parapharyngeal invasion, and carotid encasement
    Chan, Jimmy Yu Wai
    Wong, Stanley Thian Sze
    Wei, William Ignace
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2018, 40 (01): : 103 - 110
  • [24] Comparison of the Prognoses of FIGO Stage I to Stage II Adenosquamous Carcinoma and Adenocarcinoma of the Uterine Cervix Treated With Radical Hysterectomy
    Mabuchi, Seiji
    Okazawa, Mika
    Kinose, Yasuto
    Matsuo, Koji
    Fujiwara, Masateru
    Suzuki, Osamu
    Morii, Eiichi
    Kamiura, Shoji
    Ogawa, Kazuhiko
    Kimura, Tadashi
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2012, 22 (08) : 1389 - 1397
  • [25] The prognostic significance of hematological parameters in women with uterine serous papillary carcinoma (USPC)
    Younes, Grace
    Segev, Yakir
    Begal, Julia
    Auslender, Ron
    Goldberg, Yael
    Amit, Amnon
    Lavie, Ofer
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2016, 199 : 16 - 20
  • [26] The Relationship Between ERCC1 Expression and Clinical Outcome in Patients With FIGO Stage I to Stage II Uterine Cervical Adenocarcinoma
    Hasegawa, Kiyoshi
    Kato, Rina
    Torii, Yutaka
    Ichikawa, Ryoko
    Oe, Shuko
    Udagawa, Yasuhiro
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2011, 21 (08) : 1479 - 1485
  • [27] The Prognostic Value of Preoperative Serum CA125 in Endometrioid Endometrial Cancer with Cervical Stromal and Parametrial Invasion
    Ashrafganjoei, Tahereh
    Bahman, Atieh
    Hosseini, Maryam Sadat
    Arab, Maliheh
    Farzaneh, Farah
    Moridi, Atefeh
    Faghih, Nafiseh
    Sohrabi, Somayeh
    INTERNATIONAL JOURNAL OF CANCER MANAGEMENT, 2019, 12 (10) : 1 - 7
  • [28] Clinicopathological features and prognostic significance of CTNNB1 mutation in low-grade, early-stage endometrial endometrioid carcinoma
    Ruz-Caracuel, Ignacio
    Lopez-Janeiro, Alvaro
    Heredia-Soto, Victoria
    Ramon-Patino, Jorge L.
    Yebenes, Laura
    Berjon, Alberto
    Hernandez, Alicia
    Gallego, Alejandro
    Ruiz, Patricia
    Redondo, Andres
    Pelaez-Garcia, Alberto
    Mendiola, Marta
    Hardisson, David
    VIRCHOWS ARCHIV, 2021, 479 (06) : 1167 - 1176
  • [29] Adjuvant Pelvic Radiation Therapy ± Vaginal Brachytherapy in Patients With High-risk Stage I or Stage II Uterine Papillary Serous, Clear Cell, and High-grade Endometrioid Carcinoma
    Nagar, Himanshu
    Yan, Weisi
    Parashar, Bhupesh
    Nori, Dattatreyudu
    Chao, K. S. C.
    Christos, Paul
    Gupta, Divya
    Holcomb, Kevin
    Caputo, Thomas
    Wernicke, A. Gabriella
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2016, 39 (04): : 335 - 339
  • [30] Significance of abnormal peritoneal cytology on survival of women with stage I-II endometrioid endometrial cancer
    Matsuo, Koji
    Yabuno, Akira
    Hom, Marianne S.
    Shida, Masako
    Kakuda, Mamoru
    Adachi, Sosuke
    Mandelbaum, Rachel S.
    Ueda, Yutaka
    Hasegawa, Kosei
    Enomoto, Takayuki
    Mikami, Mikio
    Roman, Lynda D.
    GYNECOLOGIC ONCOLOGY, 2018, 149 (02) : 301 - 309